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Cannabis use and childhood trauma interact
additively to increase the risk of psychotic symptoms
in adolescence
M. Harley1,2, I. Kelleher1, M. Clarke1, F. Lynch2, L. Arseneault3, D. Connor1, C. Fitzpatrick2
and M. Cannon1*
1 Department of Psychiatry, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin, Ireland
2 Department of Child and Adolescent Mental Health, Mater Misericordiae University Hospital, The Children’s University Hospital Temple Street,
and University College Dublin, Dublin, Ireland
3 Medical Research Council Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, UK
Background. Adolescent cannabis use has been shown in many studies to increase the risk of later psychosis.
Childhood trauma is associated with both substance misuse and risk for psychosis. In this study our aim was to
investigate whether there is a signiﬁcant interaction between cannabis use and childhood trauma in increasing the
risk for experiencing psychotic symptoms during adolescence.
Method. Psychiatric interviews using the Schedule for Aﬀective Disorders and Schizophrenia for School-Age
Children (K-SADS) semi-structured instrument were carried out with 211 adolescents aged between 12 and 15 years
and their parents as part of a population-based study. The interview enquired about early traumatic events, cannabis
use and psychiatric symptoms in adolescence.
Results. In separate analyses both cannabis use and childhood trauma were signiﬁcantly associated with risk of
experiencing psychotic symptoms. However, the presence of both childhood trauma and early cannabis use
signiﬁcantly increased the risk for psychotic symptoms beyond the risk posed by either risk factor alone, indicating
that there was a greater than additive interaction between childhood trauma and cannabis use.
Conclusion. Our ﬁnding of a greater than additive interaction between childhood trauma and cannabis use may
have implications for the identiﬁcation of individuals at high risk of experiencing psychotic symptoms. For example,
measures to actively discourage or intensively treat cannabis use in children and adolescents who have experienced
abuse may help to prevent the development of psychosis in this vulnerable group. Our ﬁndings require replication in
larger samples to conﬁrm this interaction eﬀect.
Received 19 March 2009 ; Revised 13 October 2009 ; Accepted 13 October 2009 ; First published online 9 December 2009
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Introduction
Cannabis use has been increasing over the past few
decades (Gledhill-Hoyt et al. 2000) and age at ﬁrst use
has been decreasing in Western societies (Degenhardt
et al. 2000). There are particular concerns about the
use of cannabis in adolescence as the brain is still de-
veloping (Giedd et al. 1999) and may be vulnerable to
the potentially toxic eﬀects of cannabis (Arseneault
et al. 2002 ; Cannon et al. 2006). Cannabis use has been
found to be associated with mental health problems,
most notably psychotic disorders (Arseneault et al.
2004 ; Moore et al. 2007), although it is a matter of some
debate whether the relationship is causal in nature
(Macleod et al. 2004, 2006).
Recent studies have shown that childhood trauma
is a risk factor for the development of schizophrenia
(Read et al. 2005 ; Morgan & Fisher, 2007 ; Bendall
et al. 2008) and psychotic symptoms (Bak et al. 2005 ;
Kelleher et al. 2008). It has also been shown that
childhood trauma increases the risk of substance mis-
use in adolescence and adulthood (De Bellis, 2002 ;
Gordon, 2002). Taken together, these strands of evi-
dence point to the possibility that childhood trauma
may have a role to play in the association between
cannabis use and psychosis (Cougnard et al. 2007 ;
Houston et al. 2008).
* Address for correspondence : Professor M. Cannon, Department of
Psychiatry, Royal College of Surgeons in Ireland, Education and
Research Centre, Beaumont Hospital, Dublin 9, Ireland.
(Email : marycannon@rcsi.ie)
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There is increasing interest in the role of interactions
(gene–environment, gene–gene and environment–
environment) in the aetiology of psychiatric disorders
(van Os & Sham, 2003; Moﬃtt et al. 2005 ; Caspi &
Moﬃtt, 2006 ; van Os et al. 2008 ; Clarke et al. 2009).
However, there is some debate about the usefulness of
such ﬁndings and the correct model to use for the in-
vestigation of psychiatric outcomes (Risch et al. 2009 ;
Zammit et al. 2009). Predictions can be modelled on
either additive or multiplicative scales. A multiplicat-
ive model assumes that risks multiply in their eﬀect.
An additive model assumes that individuals can de-
velop the outcome of interest from either of the risk
factors acting alone and tests for positive deviations
from additivity (superaddivity) that indicate the
presence of synergy. The additive model is considered
to be the more meaningful model in psychiatric epi-
demiology, where diseases usually have complex
multifactorial aetiologies (Darroch, 1997 ; van Os &
Sham, 2003; Schwartz & Susser, 2006).
In this study we aimed to investigate whether the
presence of both childhood trauma and early cannabis
use increases the risk of experiencing psychotic
symptoms in adolescence beyond that expected if each
risk factor were working independently. The import-
ance of psychotic symptoms in childhood and ado-
lescence lies in mounting evidence that they are a risk
marker for later psychotic illness (Poulton et al. 2000 ;
Scott et al. 2008).
Method
Participants
The ‘Challenging Times’ study (Lynch et al. 2004,
2006 ; Mills et al. 2004) was established to investigate
the prevalence of psychiatric disorders among Irish
adolescents aged 12–15 years in an urban environ-
ment. The study was carried out in the geographical
catchment area of a Child and Adolescent Mental
Health Team in North Dublin with a population of
137 000. Participating schools were selected using a
stratiﬁed random sampling technique, stratiﬁed ac-
cording to the approximate socio-economic class of the
school to approximate to the geographical area popu-
lation. In brief, 743 pupils in eight mainstream schools
(52% of the total school population in that area) were
screened for psychiatric symptoms using the Strengths
and Diﬃculties Questionnaire (SDQ), which assesses
emotional symptoms, conduct problems, hyper-
activity/inattention, peer relationship problems, and
prosocial behaviour (Goodman, 1997 ; Goodman et al.
2000). The Children’s Depression Inventory (CDI),
which assesses cognitive, aﬀective and behavioural
signs of depression, was also used (Kovacs, 1985).
After complete description of the study to the subjects,
written informed consent was obtained from their
parent or guardian. One hundred and forty ado-
lescents scored above threshold on these instruments,
indicating high risk of having mental health problems.
Adolescents were included in this ‘at-risk ’ category
if they scored in the clinical range on the CDI and/or if
they scored in the clinical range on the SDQ, and/or if
they ticked ‘I want to kill myself ’ on item 9 of the CDI.
Of these 140 adolescents, 117 (83.6%) agreed to attend
for full psychiatric interview. A comparison group of
173 adolescents, matched for gender and school, were
also invited to attend, of whom 94 (54%) agreed.
Ethical approval for the study was granted by the
Medical Ethics Committee of the Mater Misericordiae
University Hospital, Dublin, Ireland. The study
was supported by the multi-disciplinary Child and
Adolescent Mental Health Service covering the geo-
graphical area. The protocol ensured that any ado-
lescent who was deemed to be in need of a clinical
service could be referred to the appropriate team.
Interview instrument
The interview schedule used in this study was the
Schedule for Aﬀective Disorders and Schizophrenia
for School-Age Children, Present and Lifetime
Versions (K-SADS-PL; Kaufman et al. 1996). The
K-SADS is a well-validated semi-structured research
diagnostic interview for the assessment of all Axis-I
psychiatric disorders in children and adolescents.
Children and parents were interviewed separately,
both answering the same questions about the child.
Interviews were conducted by one psychiatrist or two
psychologists who were trained in the use of the
K-SADS. Inter-rater reliability for the K-SADS was es-
timated as over 90% in this study (Lynch et al. 2006).
Psychotic symptoms
Axis I psychiatric diagnoses according to DSM-IV
(APA, 1994) were determined using the K-SADS semi-
structured interview with adolescents and parents or
guardians. The Psychosis section of the K-SADS asks
about the child’s experience of hallucinations and
delusions not occurring during acute intoxication with
a substance. Responses to these questions were re-
corded on the interview sheet. Three psychiatrists
(M.H., F.L. and M.C.) and one psychologist (I.K.)
examined these responses and concurred that the
symptoms seemed genuine in content.
Measurement of substance misuse
During the interview, in the Substance Misuse section
of the K-SADS, both adolescent and parent were asked
1628 M. Harley et al.
whether the adolescent had ever used cannabis. If the
answer was yes, then frequency of use in the past
6 months and frequency ever were recorded. Cannabis
use was deﬁned as ever having used cannabis.
Measurement of childhood trauma
As part of the K-SADS interview the following child-
hood traumatic experiences were assessed. Interviews
were conducted with parents and adolescents separ-
ately.
Childhood abuse. Both child physical abuse and child
sexual abuse were assessed as part of the K-SADS in-
terview. Adolescents were asked a series of questions
in relation to physical or sexual abuse. Parents were
asked the same questions appropriately modiﬁed.
A disclosure of physical or sexual abuse from the
parent was taken as evidence of a history of child
abuse, regardless of whether it was also disclosed by
the child. There were no cases where the parent dis-
puted the occurrence of abuse that had been disclosed
by the child.
Domestic violence. Exposure to domestic violence was
assessed in the Post-Traumatic Stress Disorder section.
Adolescents and their parents were separately asked
the same questions. A disclosure of domestic viol-
ence from the parent was taken as evidence of viol-
ence between parents/step-parents. There were no
cases where the parent’s report of the occurrence
of domestic violence disagreed with that disclosed
by the child or vice versa. Childhood trauma was de-
ﬁned as a history of physical abuse, sexual abuse,
witnessing domestic violence or any combination of
these.
Socio-economic status (SES) and family history
SES of each study participant was determined using
parental occupation assessed according to the Irish
Social Class Scale (Central Statistics Oﬃce, 1996). We
divided the sample into two major groups according
to social class : the ﬁrst group contained SES groups
1 and 2 (professional/managerial) and the second
group contained SES groups 3–7 (non-manual skilled,
skilled manual, semi-skilled manual, unskilled man-
ual, and unemployed). The K-SADS interview in-
cludes a routine screening section for family history of
psychiatric illness, which was used in the present
study. Family psychiatric history included history of
aﬀective disorders, anxiety disorders, psychotic and
substance use disorders in a ﬁrst- or second-degree
relative.
Statistical analysis
An additive model of interaction assumes that risks
add in their eﬀects so that results over and above
additivity indicate synergy. However, when examin-
ing the interaction of two risk factors, it is important to
note that some individuals can develop disease from
either one of the two risk factors under study alone;
this phenomenon is termed parallelism and it reduces
the measure of the exposures’ combined eﬀect. An
additive model of interaction therefore includes the
supperadditive eﬀect of the interaction of two causal
partners, and the subadditive eﬀect of parallelism. The
details of the analysis are as follows: if we have
two risk factors for psychosis A and B, there are four
possible exposure states, each carrying a speciﬁc risk.
Therefore, the risk in those exposed to neither A nor B
is R; the risk in those exposed to A only is R(A), the
risk in those exposed to B only is R(B), and the risk in
those exposed to both is R(AB). On the additive scale,
the eﬀect of a risk factor is expressed as a risk dif-
ference. We can therefore express the eﬀect associated
with A as R(A)xR, with B as R(B)xR and with AB
exposure as R(AB)xR. The excess of the combined
eﬀect over the sum of the solitary eﬀects of A and B is
R(AB)xR(A)xR(B)+R; this represents the statistical
additive interaction.
We wanted to examine for additive interaction
rather than multiplicative interaction in this study
(Darroch, 1997 ; van Os & Sham, 2003; Cougnard et al.
2007). Because of the case-control design of the
Challenging Times study, however, it was not possible
to estimate the baseline risk of disease and use risk
diﬀerences in this analysis. Schwartz & Susser (2006)
have described a method whereby estimates from a
multiplicative model can be used to assess interaction
on an additive scale. This adaptation allows the use of
odds ratios (ORs) instead of risk diﬀerences. In this
study, we used logistic regression for the initial
analyses and translated these to look at interaction on
an additive scale using an interaction contrast ratio
method (Rothman & Greenland, 1998; Schwartz &
Susser, 2006). This ratio is calculated as : R(AB)x
R(A)xR(B)+1.
In brief, we stratiﬁed our data into four categories :
(1) no exposure to cannabis use or childhood trauma
[R], (2) exposure to cannabis use only [R(A)], (3) ex-
posure to childhood trauma only [R(B)], and (4) ex-
posure to both cannabis use and childhood trauma
[R(AB)]. The outcome measure was self-reported psy-
chotic symptoms. The ORs for groups 2, 3 and 4 were
calculated using group 1 as baseline. The ORs were
then used in the standard formula for calculating an
interaction contrast ratio. The interaction contrast ratio
divided by the OR in those exposed to both risk factors
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can be interpreted as the proportion of disease among
those with both risk factors that is attributable to the
interaction.
All analyses were carried out using Stata Statistical
Software release 9.2 (Stata Corporation, USA).
Results
Of the 211 children in the interviewed sample, 83
(39%) received a DSM-IV Axis I diagnosis following
the K-SADS interview. The most common disorders
diagnosed were depressive disorders (17.5%, n=37).
No participant received a formal diagnosis of a psy-
chotic illness. Fourteen participants (6.6%) reported
experiencing psychotic symptoms, primarily auditory
and visual hallucinatory experiences.
Substance use
No adolescents in this sample met criteria for a can-
nabis dependence syndrome. Of the adolescents in-
terviewed, 8.5% (n=18) reported having ever used
cannabis. Only ﬁve adolescents reported ever having
used any illicit substance (ecstasy, ‘poppers’, sniﬃng
deodorant or petrol) other than cannabis and four of
these had also used cannabis. Adolescents who had
used cannabis were ﬁve times more likely to have
experienced at least one psychotic symptom (see
Table 1).
Childhood trauma
Childhood trauma was reported in 11.3% of partici-
pants interviewed (n=24). Those adolescents who had
experienced childhood trauma were almost ﬁve times
more likely to use cannabis [OR 4.86, 95% conﬁdence
interval (CI) 1.63–14.51, p=0.005] than those who
had not experienced trauma. Participants who had
experienced childhood trauma were also ﬁve times
more likely to develop psychotic symptoms (OR 5.20,
95% CI 1.58–17.13, p=0.007) compared to those who
had not (Table 1).
Examining the relationship between cannabis,
childhood trauma and psychotic symptoms
Fig. 1 shows the prevalence of psychotic symptoms in
each of the four exposure categories : No trauma or
cannabis use; Cannabis use/no trauma; Trauma/no
cannabis use ; Trauma and cannabis use. Table 2
shows the ORs for each of the four exposure categor-
ies. Using these ORs in the formula for additive inter-
action [R(AB)xR(A)xR(B)+R] gave a value of 17.4
[20.9x1.9x2.6+1]. The statistical additive interaction
is positive, indicating that childhood trauma and
cannabis use interact on the additive scale. We can
estimate from our data that 83% (17.4/20.9) of the oc-
currence of psychotic symptoms among those exposed
to both cannabis use and childhood trauma is attribu-
table to the interaction between these factors.
Discussion
In this study we found that both cannabis use and
childhood trauma increased the risk for psychotic
symptoms in adolescence in main eﬀect analyses.
However, when we examined both risk factors under
an additive model we found evidence of a greater than
additive interaction between childhood trauma and
cannabis use, whereby the eﬀect of the joint presence
Table 1. Risk of psychosis associated with childhood trauma and cannabis use as main
eﬀects
Risk factor
Total
no.
Psychosis
n (%)
Unadjusted OR
(95% CI)
Adjusted ORa
(95% CI)
Trauma 24 5 (21) 5.20 (1.6–17.1) 6.16 (1.65–23.1)
Cannabis 18 4 (22) 5.23 (1.4–18.8) 4.32 (1.1–17.3)
OR, Odds ratio ; CI, conﬁdence interval.
a Adjusted for gender, age, socio-economic status and family psychiatric history.
No trauma or
cannabis use (n=175)
Cannabis use only
(n=18)
Trauma only
(n=18)
Trauma and
cannabis use (n=6)
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Fig. 1. Percentage of adolescents with psychotic symptoms
( ) in each risk exposure category.
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of these two factors increased the likelihood of psy-
chotic symptoms in adolescence to a much greater
extent than would be expected if each risk factor were
working independently.
Several large prospective studies have examined
the association between cannabis use and psychotic
illness or psychotic symptoms, mostly in adult popu-
lations, controlling for a variety of potential con-
founding variables (Arseneault et al. 2004) ; however,
most have not considered childhood trauma as a
potential eﬀect modiﬁer. Two studies reported results
adjusted for childhood trauma (physical and/or sex-
ual abuse) in the analysis and found that a signiﬁcant
association between cannabis use and psychotic
symptoms remained even after adjustment for these
factors (Fergusson et al. 2005 ; Henquet et al. 2005),
suggesting that cannabis is an independent risk factor
for psychosis, which is in keeping with our results.
Two recent papers have looked at the possibility of
an interaction between childhood trauma and ado-
lescent cannabis use in increasing the likelihood of
psychotic symptoms and psychotic illness. Cougnard
et al. (2007) re-examined data from two large European
population cohort studies (one adult cohort, one
cohort aged 14–24 years) and calculated additive
interaction between three environmental risk factors
for psychosis (cannabis use, childhood trauma and
urbanicity) and baseline psychotic experiences in pre-
dicting persistence of psychotic experiences. The
authors concluded that the level of environmental risk
combines synergistically with subclinical psychotic
symptoms to cause abnormal persistence of these
symptoms. Houston et al. (2008) re-examined data
from the National Comorbidity Survey to investigate
the interactive eﬀect of childhood sexual abuse and
cannabis use in relation to psychotic outcomes. Unlike
our study, the authors found no main eﬀect for either
risk factor alone, but a signiﬁcant interaction between
the two. Childhood sexual trauma was signiﬁcantly
associated with psychotic symptoms in the subgroup
of adolescents who had used cannabis before the age
of 16 years.
What are the possible biological mechanisms of an
interaction eﬀect?
There are several possible biological, genetic and
psychosocial factors that could be involved in the as-
sociation between cannabis use, trauma and psychotic
symptoms. The most parsimonious explanation in-
volves eﬀects on the dopamine neurotransmitter sys-
tem. First, all eﬀective antipsychotic medications aﬀect
dopamine and dopamine sensitization has been pro-
posed as a mechanism explaining psychotic symptoms
(Laruelle, 2000 ; Kapur et al. 2005). Second, it has been
demonstrated that cannabis aﬀects dopamine release
and that the direction of eﬀect depends on the
chronicity of use (Verrico et al. 2003 ; Luzi et al. 2008 ;
Bossong et al. 2009). Third, there is evidence from both
animal (Plotsky & Meaney, 1993 ; Ladd, 1996 ; Liu et al.
2000 ; Kalinichev et al. 2002) and human studies (Heim
et al. 2000 ; Carpenter et al. 2007) that response to
severe stress, such as childhood abuse early in life,
can lead to permanent changes in the hypothalamic–
pituitary–adrenal (HPA) axis and dopamine systems
(for discussion see Read et al. 2001).
Limitations and strengths of study
Although the ORs in this study are high, the CIs are
wide, reﬂecting a relatively small sample size when
subgroups are compared. The Challenging Times
study was designed as a general epidemiological
study of mental health in adolescents, not speciﬁcally
to test the current hypotheses. Although this may have
led to less detailed information obtained speciﬁcally in
relation to cannabis use and psychotic symptoms, it is
likely that it minimized interviewer bias. Another
limitation was that information on the timing of events
(ﬁrst use of cannabis, ﬁrst experience of childhood
trauma) was limited and relied on retrospective recall.
However, recent data suggest that the temporal or-
dering of childhood trauma and cannabis use does not
aﬀect the risk of developing psychosis (Shevlin et al.
2009). Rates of cannabis use were relatively low in
this sample. This may be due to under-reporting of
Table 2. Risk of psychotic symptoms in each exposure category
Risk exposure category
Total
no.
Psychosis,
n (%) OR (95% CI) p
No cannabis use/no trauma 175 8 (4.6) 1.0 (baseline)
Cannabis use/no trauma 12 1 (8.3) 1.9 (0.04–16.5) 0.55
Trauma/no cannabis use 18 2 (11.1) 2.6 (0.25–14.6) 0.23
Trauma/cannabis use 6 3 (50.0) 20.9 (2.3–173.5) 0.000
OR, Odds ratio ; CI, conﬁdence interval.
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substance use, although participants were assured
of the conﬁdentiality of their data and collateral in-
formation was obtained from at least one parent/
guardian. It should also be noted that the measure of
sexual abuse used in this study is a conservative one,
which may explain the low rates of sexual abuse re-
ported.
The strengths of this study include the use of an
epidemiological community-based sample, whereby
schools were selected using a randomized stratiﬁed
sampling method so that the study population is rep-
resentative of the area population. A well-validated
standardized psychiatric interview was used in this
study and administered by trained researchers with a
clinical background. Information was also obtained
from parents/carers so that information on psychiatric
symptoms, on environmental risk factors, and on a
variety of potential confounding factors was available
from two sources.
Conclusions
In this study, we report a greater than additive inter-
action between childhood trauma and cannabis use in
increasing the likelihood of developing psychotic
symptoms. Our ﬁndings should be replicated in a
larger sample of adolescents using a prospective
design to clarify the temporal relationship between
risk factors and symptoms. Future studies examining
links between cannabis use and psychosis should
consider the eﬀects of childhood trauma as an im-
portant potential eﬀect modiﬁer. The ﬁndings re-
ported here may have important practical implications
for the prevention of psychosis. Young people with a
history of childhood trauma could be conceptual-
ized as an ‘at-risk ’ group and could be targeted
for psychotherapeutic intervention, if warranted, or
psycho-educational interventions concerning risks of
substance use, particularly during adolescence.
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